| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 39.56B | 37.39B | 33.14B | 37.07B | 36.21B | 30.26B |
| Gross Profit | 11.54B | 10.68B | 8.09B | 9.44B | 8.76B | 6.77B |
| EBITDA | 4.66B | 5.18B | 1.60B | 3.16B | 2.35B | 454.00M |
| Net Income | 4.04B | 3.43B | 767.00M | 1.76B | 981.00M | -28.00M |
Balance Sheet | ||||||
| Total Assets | 49.32B | 49.81B | 45.03B | 43.89B | 43.48B | 41.31B |
| Cash, Cash Equivalents and Short-Term Investments | 21.94B | 22.29B | 16.66B | 20.68B | 19.48B | 18.48B |
| Total Debt | 5.28B | 3.52B | 3.52B | 3.52B | 3.52B | 3.52B |
| Total Liabilities | 14.75B | 15.84B | 14.83B | 15.20B | 16.46B | 14.28B |
| Stockholders Equity | 34.57B | 33.97B | 30.20B | 28.70B | 27.02B | 27.03B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.12B | -725.00M | 1.34B | 1.90B | -1.05B |
| Operating Cash Flow | 0.00 | 3.33B | -322.00M | 1.59B | 2.60B | -689.00M |
| Investing Cash Flow | 0.00 | 2.33B | -3.37B | -10.00M | -904.00M | -612.00M |
| Financing Cash Flow | 0.00 | -434.00M | -324.00M | -390.00M | -594.00M | -591.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | $15.77B | 3.91 | ― | 2.11% | 22.72% | 824.03% | |
73 Outperform | ¥15.70B | 23.55 | ― | 1.02% | 24.54% | 31.33% | |
71 Outperform | ¥10.10B | 5.54 | ― | 4.55% | -2.82% | 18.67% | |
70 Outperform | ¥10.75B | 12.53 | ― | 2.87% | 16.82% | 52.74% | |
70 Outperform | ¥15.10B | 23.77 | ― | 2.54% | 4.58% | 13.71% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
62 Neutral | ¥8.53B | 13.61 | ― | 2.02% | 0.55% | 95.43% |